Seroprevalence of Rift Valley fever, Q fever, and brucellosis in ruminants on the southeastern shore of Lake Chad
GHDx Entry last modified on: May 30, 2020
Scientific literature
Displaying 48301 - 48350 of 59997
Seroprevalence of rubella in Kinshasa (Zaire)
GHDx Entry last modified on: Feb 22, 2024
Seroprevalence of rubella in pregnant women in Kashmir
GHDx Entry last modified on: May 30, 2020
Seroprevalence of SARS-CoV-2 after the Second Wave in South Africa in HIV-Infected and Uninfected Persons: A Cross-Sectional Household Survey, November 2020 - April 2021. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 among adults in three regions of France following the lockdown and associated risk factors: a multicohort study. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 Among Frontline Healthcare Personnel During the First Month of Caring for Patients With COVID-19-Nashville, Tennessee
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2 antibodies among healthy blood donors in Karachi, Pakistan
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 antibodies in 2115 blood donors from Romania
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 Antibodies in Adults and Healthcare Workers in Southern Italy
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2 antibodies in an entirely PCR-sampled and quarantined community after a COVID-19 outbreak - the CoNAN study. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Campeche Mexico
GHDx Entry last modified on: Apr 10, 2023
Seroprevalence of SARS-CoV-2 antibodies in Saint Petersburg, Russia: a population-based study
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 antibodies in Saint Petersburg, Russia: a population-based study. Preprint
GHDx Entry last modified on: Sep 21, 2021
Seroprevalence of SARS-CoV-2 antibodies in Seattle, Washington: October 2019-April 2020
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2 antibodies in South Korea
GHDx Entry last modified on: Dec 19, 2023
Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study
GHDx Entry last modified on: Apr 10, 2023
Seroprevalence of SARS-CoV-2 IgG Antibodies in Corsica (France), April and June 2020
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2 IgG antibodies in two regions of Estonia (KoroSero-EST-1)
GHDx Entry last modified on: Jun 17, 2021
Seroprevalence of SARS-CoV-2 IgG Antibodies in Utsunomiya City, Greater Tokyo, after first pandemic in 2020 (U-CORONA): a household- and population-based study. Preprint.
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 IgG antibody among healthy blood donors: a single centre study
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2 IgM and IgG antibodies in an asymptomatic population in Sergipe, Brazil
GHDx Entry last modified on: Jun 17, 2021
Seroprevalence of SARS-CoV-2 immunoglobulin antibodies in Wuhan, China: part of the city-wide massive testing campaign
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2 in blood donors from the Lodi Red Zone and adjacent Lodi metropolitan and suburban area
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 in Mazandaran province, Iran
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 in migrant workers in Kuwait
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 in Palestine: a cross-sectional seroepidemiological study. Preprint.
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 in slums and non-slums of Mumbai, India, during June 29-July 19, 2020. Preprint.
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 in slums versus non-slums in Mumbai, India
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2 in the West Bank region of Palestine: a cross-sectional seroepidemiological study
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 in Utsunomiya City, Greater Tokyo, after the first pandemic in 2020
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 infection among children in Children's Hospital Zagreb during the initial and second wave of COVID-19 pandemic in Croatia
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 Infection Among Occupational Groups from Bucaramanga Metropolitan Area, Colombia. Preprint
GHDx Entry last modified on: Oct 5, 2022
Seroprevalence of SARS-CoV-2 Infection and Adherence to Preventive Measures in Cuenca, Ecuador, October 2020, a Cross-Sectional Study
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 infection in a municipality in southern Brazil
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2 infection in the Colombo Municipality region, Sri Lanka. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 infection in the craft and manual worker population of Qatar
GHDx Entry last modified on: Jun 17, 2021
Seroprevalence of SARS-CoV-2 significantly varies with age: Preliminary results from a mass population screening
GHDx Entry last modified on: Jun 17, 2021
Seroprevalence of SARS-CoV-2 specific IgG antibodies in District Srinagar, northern India - A cross-sectional study
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2, symptom profiles and seroneutralization during the first COVID-19 wave in a suburban area, France. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2-Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2-specific antibodies in Sydney after the first epidemic wave of 2020
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2-Specific Antibodies, Faroe Islands
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2-Specific IgG Antibodies Among Adults Living in Connecticut: Post-Infection Prevalence (PIP) Study
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2-Specific IgG Antibodies Among Adults Living in Connecticut: Post-Infection Prevalence (PIP) Study. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 IgG in Juba, South Sudan, 2020<sup>1</sup>
GHDx Entry last modified on: May 12, 2022
Seroprevalence of severe acute respiratory syndrome coronavirus 2 in Slovenia: results of two rounds of a nationwide population study on a probability-based sample, challenges and lessons learned
GHDx Entry last modified on: May 12, 2022
Seroprevalence of sexually transmitted infections among accepted and deferred blood donors in Jamaica
GHDx Entry last modified on: Jul 20, 2021
Seroprevalence of sexually transmitted infections in blood donors from the state blood transfusion center, Tlaxcala, Mexico
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of sexually transmitted viruses in Korean populations including HIV-seropositive individuals
GHDx Entry last modified on: Mar 3, 2019
